Cyclohexyl prostaglandin analogs as ep4-receptor agonists

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/557 (2006.01) A61K 31/662 (2006.01) A61P 27/06 (2006.01) C07C 49/753 (2006.01) C07C 69/743 (2006.01) C07C 235/30 (2006.01) C07D 257/04 (2006.01) C07F 9/08 (2006.01)

Patent

CA 2537252

The invention relates to the use of novel cyclohexyl analogues of E-type prostaglandins as EP4 agonists, in general, and, in particular as ocular hypotensives. The cyclohexyl analogues used in accordance with the invention are represented by the following formula I wherein the wavy segments represent .alpha. or .beta. bond, dashed line represents the presence or absence of a bond W, Y, Z, R, R1 , R2 and R3 are as defined in the specification.

L'invention porte sur l'utilisation de nouveaux analogues de cyclohexyle des prostaglandines de type E comme agonistes d'EP¿4?, en général et, en particulier, comme hypotenseurs oculaires. Les analogues de cyclohexyle utilisés selon l'invention sont représentés par la formule (I) dans laquelle les segments ondulés représentent a ou une liaison .szlig., la ligne pointillée représente la présence ou l'absence d'une liaison W, Y, Z, R, R?1¿, R?2¿ et R?3¿ sont tels que définis dans la demande.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cyclohexyl prostaglandin analogs as ep4-receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclohexyl prostaglandin analogs as ep4-receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclohexyl prostaglandin analogs as ep4-receptor agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1664134

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.